跳转到内容

富马地罗昔美

维基百科,自由的百科全书
富马地罗昔美
临床资料
商品名英语Drug nomenclatureVumerity
其他名称ALKS-8700
AHFS/Drugs.comMonograph
MedlinePlusa620002
核准状况
怀孕分级
给药途径口服给药
ATC码
法律规范状态
法律规范
药物动力学数据
血浆蛋白结合率Monomethyl fumarate (MMF): 27–45%
药物代谢Esterases, citric acid cycle
代谢产物MMF (active), hydroxyethyl succinimide (HES, inactive), CO2 (inactive)
生物半衰期1 hour
排泄途径MMF: 60% lung, 15.5% urine (?), 0.9% faeces
HES: 58–63% urine
识别信息
CAS号1577222-14-0
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard英语CompTox Chemicals Dashboard (EPA)
化学信息
化学式C11H13NO6
摩尔质量255.23 g·mol−1
3D模型(JSmol英语JSmol
  • COC(=O)C=CC(=O)OCCN1C(=O)CCC1=O
  • InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+
  • Key:YIMYDTCOUQIDMT-SNAWJCMRSA-N

富马地罗昔美(英语:Diroximel fumarate,商品名:Vumerity)是一种含氮有机化合物,化学式为C11H13NO6,用于治疗复发型多发性硬化症(MS)[3][5][6]

参考文献

[编辑]
  1. ^ 1.0 1.1 Vumerity APMDS. Therapeutic Goods Administration (TGA). 4 April 2022 [24 April 2022]. 
  2. ^ Updates to the Prescribing Medicines in Pregnancy database. Therapeutic Goods Administration (TGA). 21 December 2022 [2 January 2023]. 
  3. ^ 3.0 3.1 Vumerity- diroximel fumarate capsule. DailyMed. [1 February 2021]. (原始内容存档于5 February 2021). 
  4. ^ Vumerity EPAR. European Medicines Agency. 14 September 2021 [24 November 2021]. (原始内容存档于25 November 2021). 
  5. ^ Wang Y, Bhargava P. Diroximel fumarate to treat multiple sclerosis. Drugs of Today. July 2020, 56 (7): 431–437. PMID 32648853. S2CID 220471534. doi:10.1358/dot.2020.56.7.3151521. 
  6. ^ Kourakis S, Timpani CA, de Haan JB, Gueven N, Fischer D, Rybalka E. Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?. Pharmaceuticals (Basel, Switzerland). October 2020, 13 (10): 306. PMC 7602023可免费查阅. PMID 33066228. doi:10.3390/ph13100306可免费查阅.